---
layout: post
title: "Food and Drug Administration/Federal Trade Commission Workshop on a Competitive Marketplace for Biosimilars; Public Workshop; Request for Comments"
date: 2026-02-05 19:08:24 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2020-02101
original_published: 2020-02-04 00:00:00 +0000
significance: 8.00
---

# Food and Drug Administration/Federal Trade Commission Workshop on a Competitive Marketplace for Biosimilars; Public Workshop; Request for Comments

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 04, 2020 00:00 UTC
**Document Number:** 2020-02101

## Summary

The Food and Drug Administration (FDA, the Agency, or we), in collaboration with the Federal Trade Commission (FTC), is announcing a public workshop on March 9, 2020, "FDA/FTC Workshop on a Competitive Marketplace for Biosimilars." The purpose of the public workshop is to discuss FDA and FTC's collaborative efforts to support appropriate adoption of biosimilars, discourage false or misleading communications about biosimilars, and deter anticompetitive behaviors in the biologic product marketplace.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2020/02/04/2020-02101/food-and-drug-administrationfederal-trade-commission-workshop-on-a-competitive-marketplace-for)
- API: https://www.federalregister.gov/api/v1/documents/2020-02101

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
